Search Results 681-690 of 18517 for Relapse
A Study to Evaluate Feasibility of In Vivo Sensitivity Screen Using Direct Tumor Microinjection and FDG-PET in Patients with Relapsed/Refractory Non-Hodgkin ...
... Relapsed or Refractory NHL. The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or ...
... Relapsed or Refractory Multiple Myeloma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...
Events include primary or secondary graft failure, receipt of a second Hematopoietic Cell Transplantation or Gene Therapy, relapse of one or more Chronic ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18, 2013. Cancer. Mayo Clinic Receives $8.8 Million Federal Grant for Metabolomics ...
The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...
Topics include relapse prevention, mindfulness and the physiology of addiction. “You've got to get away from your life, manage depression and anxiety, learn ...
... (relapsed) or that has not responded to previous treatment (refractory). ... relapse. The cohorts will start in ... Long-Term Study of Participants ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.